Volume 376, Issue 9750, Pages (October 2010)

Slides:

Advertisements

Similar presentations

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Advertisements

Volume 376, Issue 9753, Pages (November 2010)

Volume 1, Issue 4, Pages (October 2015)

Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study Dr Jack R W Brownrigg,

Volume 373, Issue 9659, Pages (January 2009)

Volume 2, Issue 8, Pages (August 2015)

Pathogenesis of urinary tract infections with normal female anatomy

Volume 6, Issue 8, Pages e1 (August 2009)

Volume 361, Issue 9352, Pages (January 2003)

Testosterone and temperament traits in men: Longitudinal analysis

Volume 13, Issue 3, Pages (March 2016)

Volume 387, Issue 10022, Pages (March 2016)

Volume 376, Issue 9750, Pages (October 2010)

The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis Dr Michael Roerecke, PhD, Prof Janusz Kaczorowski,

Pharmacogenetics and future drug development and delivery

Volume 56, Issue 1, Pages (July 1969)

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies The Emerging.

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials Cholesterol.

Proinflammatory HLA-DRB1

Long-term effects of hormone replacement therapy

Volume 14, Issue 9, Pages (August 2013)

Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study Dr Danish Saleheen, PhD,

Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN

Volume 371, Issue 9609, Pages (January 2008)

Volume 4, Issue 10, Pages e457-e464 (October 2017)

Long-term effects of hormone replacement therapy

A twin with Cushing's disease

Apolipoprotein E-containing high-density lipoprotein (HDL) modifies the impact of cholesterol-overloaded HDL on incident coronary heart disease risk:

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies The Emerging.

Volume 366, Issue 9499, Pages (November 2005)

Volume 1, Issue 4, Pages (October 2015)

Characteristics and survival of patients with Ebola virus infection, malaria, or both in Sierra Leone: a retrospective cohort study Matthew Waxman, MD,

Exploring the heart of the human heart

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials Cholesterol.

Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:

Gene therapy—where are we?

Volume 9, Issue 7, Pages (July 2010)

SNPs and coronary heart disease – Authors' reply

Description of studies for pooled analyses

Volume 9, Issue 10, Pages (October 2008)

Organisation of the care of patients with heart failure

Disease and stigma The Lancet Volume 354, (December 1999)

Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies

Statin use before diabetes diagnosis and risk of microvascular disease: a nationwide nested matched study Sune F Nielsen, PhD, Prof Børge G Nordestgaard,

Resuscitation at birth and cognition at 8 years of age: a cohort study

Maternal pre-pregnancy infection with hepatitis B virus and the risk of preterm birth: a population-based cohort study Jue Liu, PhD, Shikun Zhang, MD,

Volume 352, Pages S15-S18 (October 1998)

Volume 379, Issue 9822, Pages (March 2012)

Bruce Neal, Fiona Turnbull The Lancet

Volume 5, Issue 11, Pages (November 2018)

Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall.

MRC/BHF Heart Protection Study

Confessions of a journal junkie

Volume 376, Issue 9753, Pages (November 2010)

Volume 376, Issue 9750, Pages (October 2010)

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials Cholesterol.

C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study Heart Protection.

Volume 377, Issue 9771, Pages (March 2011)

Volume 371, Issue 9628, Pages (June 2008)

Volume 379, Issue 9822, Pages (March 2012)

Volume 378, Issue 9798, (October 2011)

Volume 379, Issue 9822, Pages (March 2012)

Epidemiology of stroke

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies The Emerging.

Baseline Characteristics of the Subjects*

Volume 376, Issue 9734, Pages (July 2010)

Volume 383, Issue 9921, Pages (March 2014)

Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm

The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis Dr Michael Roerecke, PhD, Prof Janusz Kaczorowski,

A disease of the osteoblast

Presentation transcript:

Volume 376, Issue 9750, Pages 1393-1400 (October 2010) A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses Dr Samuli Ripatti, PhD, Emmi Tikkanen, MSc, Prof Marju Orho-Melander, PhD, Aki S Havulinna, MSc, Kaisa Silander, PhD, Amitabh Sharma, PhD, Candace Guiducci, BS, Prof Markus Perola, MD, Antti Jula, MD, Juha Sinisalo, MD, Marja-Liisa Lokki, PhD, Prof Markku S Nieminen, MD, Olle Melander, MD, Prof Veikko Salomaa, MD, Prof Leena Peltonen, PhD, Sekar Kathiresan, MD The Lancet Volume 376, Issue 9750, Pages 1393-1400 (October 2010) DOI: 10.1016/S0140-6736(10)61267-6 Copyright © 2010 Elsevier Ltd Terms and Conditions

Figure Distributions at baseline of genetic risk score, LDL cholesterol, systolic blood pressure, and log-transformed C-reactive protein by 10-year incident coronary heart disease event status in FINRISK 1992 and 1997 cohorts Data for C-reactive protein only available in FINRISK 1997. CHD=coronary heart disease. The Lancet 2010 376, 1393-1400DOI: (10.1016/S0140-6736(10)61267-6) Copyright © 2010 Elsevier Ltd Terms and Conditions